Rocket


Overview
Financials
News + Filings

 
 

Curative Biotechnology Inc Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-21Dec-31-20
Revenues6.14.8
            Revenue growth27.0% 
Cost of goods sold1.00.1
Gross profit5.14.7
            Gross margin83.4%97.0%
Research and development0.8 
General and administrative4.24.6
EBIT-5.0-4.6
            EBIT margin-81.8%-95.6%
Pre-tax income-5.3-4.7
Income taxes0.00.0
            Tax rate0.0%0.0%
Net income-18.8-4.7
            Net margin-307.9%-97.1%
 
Diluted EPS($15.02)($5.72)
Shares outstanding (diluted)1.30.8
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy